In this guide
Ipamorelin is a synthetic pentapeptide — five amino acids — classified as a growth-hormone secretagogue (GHS). Rather than acting as growth hormone itself, it signals the pituitary gland to release the body's own GH in a natural pulse. Among the compounds in its class, it's known for being one of the most selective, which is the whole reason it earned a place in the research literature.
How the secretagogue mechanism works
Ipamorelin is a ghrelin mimetic: it binds the growth-hormone secretagogue receptor (GHS-R1a), the same receptor the natural hunger-and-GH hormone ghrelin acts on. Activating that receptor on the pituitary triggers a pulse of stored growth hormone. Because it works through the body's own release machinery rather than replacing GH directly, the response stays pulsatile — a brief, natural-shaped spike rather than a flat, continuous level.
Why the "clean pulse" matters
The reason Ipamorelin stands out is selectivity. Earlier secretagogues in the same family — compounds like GHRP-6 and GHRP-2 — also nudge appetite hormones, cortisol, and prolactin when they release GH. In the foundational research that introduced Ipamorelin, it prompted growth-hormone release without meaningfully raising cortisol, prolactin, or ACTH, which is what led researchers to describe it as the first genuinely selective GH secretagogue.1 That clean profile is why it remains a reference compound for studying the GH axis without confounding hormonal noise.
Why it's paired with CJC-1295
Ipamorelin is most often studied alongside CJC-1295, and the pairing isn't arbitrary — the two act on different receptors. Ipamorelin hits the ghrelin receptor, while CJC-1295 is a GHRH analog that engages the growth-hormone-releasing-hormone receptor. Stimulating both pathways at once produces a larger, more complete GH response than either alone, which is why the CJC-1295 / Ipamorelin blend is one of the most common combinations in growth-hormone-axis research. We map the full axis in our growth-hormone peptide guide.
Researching the GH axis? Ipamorelin is available on its own or in a pre-mixed research blend with CJC-1295 — third-party tested, with a published COA.
View IpamorelinFrequently asked questions
What class of compound is Ipamorelin? A growth-hormone secretagogue — specifically a selective ghrelin-receptor (GHS-R) agonist that prompts the pituitary to release GH.
Why is it called "selective"? Because it stimulates GH release without significantly raising cortisol and prolactin, unlike older secretagogues in the same family.
Why combine it with CJC-1295? The two act on different receptors — the ghrelin receptor and the GHRH receptor — so together they produce a fuller GH response than either compound alone.
Is Ipamorelin approved for human use? No. It is sold strictly for in-vitro research and laboratory use only and is not intended for human consumption.
Research references
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561. PubMed ↗
For in-vitro research and laboratory use only. Not for human consumption. References are provided for scientific context and do not constitute a product claim.